Tumor Infiltrating Mast Cells (TIMs) Confers a Marked Survival Advantage in Nonmetastatic Clear-Cell Renal Cell Carcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor Infiltrating Mast Cells (TIMs) Confers a Marked Survival Advantage in Nonmetastatic Clear-Cell Renal Cell Carcinoma
Authors
Keywords
Mast Cell, Renal Cell Carcinoma, Sunitinib, Tryptase, Validation Cohort
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume 24, Issue 5, Pages 1435-1442
Publisher
Springer Nature
Online
2016-11-29
DOI
10.1245/s10434-016-5702-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Kidney Cancer
- (2017) Robert J. Motzer et al. Journal of the National Comprehensive Cancer Network
- Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy
- (2016) Alain Ravaud et al. NEW ENGLAND JOURNAL OF MEDICINE
- EAU Guidelines on Renal Cell Carcinoma: 2014 Update
- (2015) Borje Ljungberg et al. EUROPEAN UROLOGY
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Galectin-9 predicts postoperative recurrence and survival of patients with clear-cell renal cell carcinoma
- (2015) Hangcheng Fu et al. TUMOR BIOLOGY
- Mast Cell Function
- (2014) Elaine Zayas Marcelino da Silva et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Mast cells and macrophages exert beneficial and detrimental effects on tumor progression and angiogenesis
- (2013) Domenico Ribatti IMMUNOLOGY LETTERS
- Novel Immunotherapeutic Strategies in Development for Renal Cell Carcinoma
- (2012) Brant A. Inman et al. EUROPEAN UROLOGY
- Cutting Edge: Mast Cells Critically Augment Myeloid-Derived Suppressor Cell Activity
- (2012) S. J. Saleem et al. JOURNAL OF IMMUNOLOGY
- Mast Cell Interleukin-2 Production Contributes to Suppression of Chronic Allergic Dermatitis
- (2011) Alon Y. Hershko et al. IMMUNITY
- Flow cytometric mast cell-mediated cytotoxicity assay: A three-color flow cytometric approach using monoclonal antibody staining with annexin V/propidium iodide co-labeling to assess human mast cell-mediated cytotoxicity by fluorosphere-adjusted counts
- (2011) Öner Özdemir JOURNAL OF IMMUNOLOGICAL METHODS
- Crosstalk between Mast Cells and Pancreatic Cancer Cells Contributes to Pancreatic Tumor Progression
- (2010) M. J. Strouch et al. CLINICAL CANCER RESEARCH
- Mast Cells Have Prognostic Value in Merkel Cell Carcinoma
- (2009) Trevor W Beer et al. AMERICAN JOURNAL OF DERMATOPATHOLOGY
- Combination of peritumoral mast cells and T-regulatory cells predicts prognosis of hepatocellular carcinoma
- (2009) Min-Jie Ju et al. CANCER SCIENCE
- Immunological microenvironment in prostate cancer: High mast cell densities are associated with favorable tumor characteristics and good prognosis
- (2009) Achim Fleischmann et al. PROSTATE
- Prognostic influence of tumor-infiltrating mast cells in patients with follicular lymphoma treated with rituximab and CHOP
- (2008) M. Taskinen et al. BLOOD
- SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment
- (2008) B. Huang et al. BLOOD
- Colorectal Cancer Expression of Peroxisome Proliferator-Activated Receptor γ (PPARG, PPARgamma) Is Associated With Good Prognosis
- (2008) Shuji Ogino et al. GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started